Document Detail


Changes in brain intracellular pH and membrane phospholipids on oxygen therapy in hypoxic patients with chronic obstructive pulmonary disease.
MedLine Citation:
PMID:  12603086     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Chronic hypoxia due to chronic obstructive pulmonary disease (COPD) constitutes a stress to cerebral metabolic homeostasis. Previous studies using phosphorus-31 magnetic resonance spectroscopy (31P MRS) have suggested that the brains of such patients utilize anaerobic glycolysis, which in neonatal, animal, and in vitro studies is associated with a protective intracellular alkalosis. To identify such a compensatory intracellular alkalosis in hypoxic COPD patients, in vivo cerebral 31P MRS was performed in eight patients and eight controls. The mean intracellular pH (pHi) in patients with COPD was similar to that of age-matched controls, but decreased in the patients with COPD by a mean pHi of 0.02 (p = 0.04), following supplemental oxygen. There was no change in cerebral pHi in normal subjects following oxygen administration. The broadband component of the MR spectrum increased in all the patients with COPD (p = 0.01), suggesting altered phospholipid membrane fluidity in the brain associated with the change in pHi following oxygen administration. The change in the broadband resonance was strongly correlated with the change in pHi (r = -0.68, p = 0.014). This study suggests that patients with COPD exhibit a compensatory change in pHi and abnormalities in cerebral membrane phospholipid conformation in the face of chronic hypoxia.
Authors:
G Hamilton; R Mathur; J M Allsop; D M Forton; N S Dhanjal; R J Shaw; S D Taylor-Robinson
Related Documents :
14619336 - Decreased glucocorticoid binding affinity to glucocorticoid receptor is important in th...
20872566 - Nitrite in exhaled breath condensate as a marker of nitrossative stress in the airways ...
21377066 - Changes in gastroesophageal reflux in patients with nasogastric tube followed by percut...
19479666 - Reslizumab, a humanized anti-il-5 mab for the treatment of eosinophil-mediated inflamma...
8857116 - Pulmonary oedema, pneumonia and mortality in submersion victims; a retrospective study ...
17196046 - The boundary between hypochondriasis and obsessive-compulsive disorder: a cross-section...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Metabolic brain disease     Volume:  18     ISSN:  0885-7490     ISO Abbreviation:  Metab Brain Dis     Publication Date:  2003 Mar 
Date Detail:
Created Date:  2003-02-26     Completed Date:  2003-05-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8610370     Medline TA:  Metab Brain Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  95-109     Citation Subset:  IM    
Affiliation:
The Robert Steiner Magnetic Resonance Imaging Unit, MRC Clinical Sciences Centre, Faculty of Medicine, Hammersmith Hospital Campus, Imperial College, London, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Anoxia / drug therapy*,  etiology,  metabolism*
Brain / metabolism*
Chronic Disease
Control Groups
Female
Gases / blood
Humans
Hydrogen / metabolism*
Hydrogen-Ion Concentration
Intracellular Membranes / metabolism
Magnetic Resonance Spectroscopy
Male
Membranes / metabolism
Middle Aged
Oxygen / therapeutic use*
Phospholipids / metabolism*
Pulmonary Disease, Chronic Obstructive / complications*
Chemical
Reg. No./Substance:
0/Gases; 0/Phospholipids; 1333-74-0/Hydrogen; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alanine prevents the in vitro inhibition of glycolysis caused by phenylalanine in brain cortex of ra...
Next Document:  The codons 8/9 (+G) mutation found for the first time in the Lebanese population.